These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27774327)
41. Cholestasis and renal failure in a patient with secondary amyloidosis. Unsal C; Paydaş S; Gönlüşen G Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208 [TBL] [Abstract][Full Text] [Related]
42. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years. Wixner J; Suhr OB; Anan I Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):73-81. PubMed ID: 29073801 [TBL] [Abstract][Full Text] [Related]
43. Striking cholestatic liver disease: a distinct manifestation of advanced primary amyloidosis. Rockey DC South Med J; 1999 Feb; 92(2):236-41. PubMed ID: 10071676 [TBL] [Abstract][Full Text] [Related]
44. Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis. Muhammad Khan M; Ur Rashid M; Ullah W; Hussain I; Hurairah A BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31996385 [TBL] [Abstract][Full Text] [Related]
45. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Utz JP; Swensen SJ; Gertz MA Ann Intern Med; 1996 Feb; 124(4):407-13. PubMed ID: 8554249 [TBL] [Abstract][Full Text] [Related]
46. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review. Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998 [TBL] [Abstract][Full Text] [Related]
47. Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Mereuta OM; Theis JD; Vrana JA; Law ME; Grogg KL; Dasari S; Chandan VS; Wu TT; Jimenez-Zepeda VH; Fonseca R; Dispenzieri A; Kurtin PJ; Dogan A Blood; 2014 Mar; 123(10):1479-82. PubMed ID: 24415538 [TBL] [Abstract][Full Text] [Related]
49. A Rare Nasopharyngeal Presentation of Amyloidosis. Crosetti E; Manca A; Maldi E; Succo G Ear Nose Throat J; 2021 Sep; 100(8):562-565. PubMed ID: 32228034 [TBL] [Abstract][Full Text] [Related]
50. Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins. Iwata T; Hoshii Y; Kawano H; Gondo T; Takahashi M; Ishihara T; Yokota T; Ueda J; Uchino F Hum Pathol; 1995 Oct; 26(10):1148-53. PubMed ID: 7557950 [TBL] [Abstract][Full Text] [Related]
51. Severe intrahepatic cholestasis in an elderly patient with primary amyloidosis and colon adenocarcinoma. Liu CJ; Chien RN; Huang SF; Chiang JM Chang Gung Med J; 2004 Jan; 27(1):74-9. PubMed ID: 15074894 [TBL] [Abstract][Full Text] [Related]
52. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen. Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140 [TBL] [Abstract][Full Text] [Related]
53. Evolving landscape in the management of transthyretin amyloidosis. Hawkins PN; Ando Y; Dispenzeri A; Gonzalez-Duarte A; Adams D; Suhr OB Ann Med; 2015; 47(8):625-38. PubMed ID: 26611723 [TBL] [Abstract][Full Text] [Related]
54. Amyloidoma of the Tongue: Case Report, Surgical Management, and Review of the Literature. Adamo D; Gasparro R; Marenzi G; Mascolo M; Cervasio M; Cerciello G; De Novellis D; Mignogna MD J Oral Maxillofac Surg; 2020 Sep; 78(9):1572-1582. PubMed ID: 32442425 [TBL] [Abstract][Full Text] [Related]
55. Primarily isolated hepatic involvement of amyloidosis: A case report and overview. Ye L; Shi H; Wu HM; Wang FY Medicine (Baltimore); 2016 Dec; 95(52):e5645. PubMed ID: 28033255 [TBL] [Abstract][Full Text] [Related]
56. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study. Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234 [TBL] [Abstract][Full Text] [Related]
57. Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report. Yamagata A; Uchida T; Yamada Y; Nakanishi T; Nagai K; Imakiire T; Oshima N; Kumagai H BMC Nephrol; 2017 Dec; 18(1):377. PubMed ID: 29287589 [TBL] [Abstract][Full Text] [Related]
58. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis]. Mikhaleva LM; Gioeva ZV; Rёken K Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775 [TBL] [Abstract][Full Text] [Related]
59. Massive Hepatomegaly Secondary to Amyloidosis with Normal Liver Chemistries. Doe-Williams S; Hixson LJ; Pfeiffer DC Case Rep Gastroenterol; 2020; 14(2):271-278. PubMed ID: 32518538 [TBL] [Abstract][Full Text] [Related]
60. A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis. Celtik A; Sen S; Keklik F; Saydam G; Asci G; Sarsik B; Ozkahya M; Toz H Int Urol Nephrol; 2020 Jul; 52(7):1297-1304. PubMed ID: 32529382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]